U.S. Officials Approve First Long-Acting Drug to Protect Babies and Toddlers Against Severe RSV
The U.S. Food and Drug Administration (FDA) has granted approval for the first long-acting drug designed to safeguard infants and young children against respiratory syncytial virus (RSV), a common virus that can lead to severe illness in young children. RSV is typically a mild illness for healthy individuals, but it...
